Skip to content

An observational study on the effect of perioperative estrogen on length of hospital stay in patients undergoing thyroid cancer cancer surgery

An observational study on the effect of perioperative estrogen on length of hospital stay in patients undergoing thyroid cancer surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078754
Enrollment
Unknown
Registered
2023-12-18
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

The oestrogen level was lower than that in the normal group:NA
Those whose normal estrogen range is NOR group:NA

Sponsors

Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hebei Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 40-50 years old; (2) Pre-menopausal women; (3) Unilateral thyroid cancer, tumor less than 3cm, no metastasis; (4) Vital signs are stable, consciousness is clear, and a certain level of expression is available; (5) Patients who voluntarily participate in this study and sign an informed consent form; (6) Those who are not dependent on drugs or alcohol; (7) Retrograde surgery.

Exclusion criteria

Exclusion criteria: (1) Those who need to undergo other different types or parts of surgeries at the same time as the surgery; (2) Have a history of hormone drug treatment in the past six months; (3) Women who are pregnant or lactating; (4) Menstrual disorders or menopause due to unnatural reasons such as premature ovarian failure, hysterectomy, etc.; (5) Patients with malignant tumors, autoimmune system diseases, blood system diseases, serious organ diseases, etc. (6) Dropout cases; (7) Diabetic patients; (8) There are other conditions that the researcher judges to be unsuitable for participation in this clinical study.

Design outcomes

Primary

MeasureTime frame
length of stay;

Secondary

MeasureTime frame
Patient's blood pressure on 1d, 2d, and 3d after surgery;postoperative drainage volume;Drainage tube removal time;Preoperative and postoperative anxiety scale;feel sick and vomit;Opioid dosage;

Countries

China

Contacts

Public ContactFu Yue

Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hebei Province

499942667@qq.com+86 187 3303 1073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026